97541653 - KRAZATI

Information

  • Trademark
  • 97541653
  • Serial Number
    97541653
  • Registration Number
    7159329
  • Filing Date
    August 09, 2022
    2 years ago
  • Registration Date
    September 05, 2023
    a year ago
  • Transaction Date
    June 25, 2024
    6 months ago
  • Status Date
    September 05, 2023
    a year ago
  • Published for Opposition Date
    February 07, 2023
    a year ago
  • Location Date
    August 01, 2023
    a year ago
  • First Use Anywhere Date
    December 13, 2022
    2 years ago
  • First Use In Commerce Date
    December 13, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SINGLETON, RUDY RENWIC
  • Attorney Docket Number
    00163766-US
    Attorney Name
    Marilyn F. Kelly
    Law Office Assigned Location Code
    L20
  • Owners
Mark Drawing Code
5
Mark Identification
KRAZATI
Case File Statements
  • DM0000: The mark consists of the stylized term "KRAZATI". The black background in this mark drawing represents background and/or transparent areas only and is not claimed as a feature of this mark.
  • GS0051: pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
Case File Event Statements
  • 8/29/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/12/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/28/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/29/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/29/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/29/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/30/2022 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/30/2022 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/31/2022 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/31/2022 - a year ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/18/2023 - a year ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/7/2023 - a year ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/7/2023 - a year ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/4/2023 - a year ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/19/2023 - a year ago
    15 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 4/19/2023 - a year ago
    17 - USE AMENDMENT FILED Type: IUAF
  • 5/8/2023 - a year ago
    16 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/9/2023 - a year ago
    18 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 8/1/2023 - a year ago
    19 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 8/2/2023 - a year ago
    20 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 9/5/2023 - a year ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/5/2023 - a year ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/25/2024 - 6 months ago
    25 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/25/2024 - 6 months ago
    23 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/25/2024 - 6 months ago
    24 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA